skip to main content

Our response to the Covid-19 outbreak.

Featured Items

End the war on drugs to help fix American policing
Why Covid-19 will challenge a major model of addiction
Vaping: Clearing the Air
Drug Treatment Gaps in Harris County, Texas
Predicting arrests but little else
The case for marijuana decriminalization
Marijuana as Medicine
Prison drug treatment could curb opioid crisis
Syringe Exchange: Sound Science, Proven Policy
Drugs By The Numbers

About The Program

Policy regarding drugs, both legal and illegal and explicitly including alcohol, poses some of the most prominent and perplexing issues facing modern societies. For nearly a century, the United States has been an active proponent of the punitive prohibition of illicit drugs. Unfortunately, the “War on Drugs” has been largely unsuccessful; prosecution of illegal drug consumption has filled our prisons without significantly reducing crime, decreasing homelessness, preventing overdose deaths.

Read More about the Drug Policy Program

Sign up for our mailing list

Fellows & Scholars

William Martin

William Martin, Ph.D., is the Harry and Hazel Chavanne Senior Fellow in Religion and Public Policy at the Baker Institute and the Chavanne Emeritus …
Read more about this expert

Katharine Neill Harris

Katharine Neill Harris, Ph.D., is the Alfred C. Glassell, III, Fellow in Drug Policy at Rice University’s Baker Institute for Public Policy. Her current …
Read more about this expert

  1. Katharine Neill Harris, Drug Policy, <QuerySet []>
  2. Gary J. Hale, Center for the U.S. and Mexico, <QuerySet [<ResearchFocus: Drug Policy>]>
  3. Lisa Pittman, Drug Policy, <QuerySet []>
  4. David R. Brockman, Religion & Public Policy, <QuerySet []>
  5. Kevin Erickson, Center for Health and Biosciences, <QuerySet [<ResearchFocus: Domestic Health Policy>]>
  6. Drury Stevenson, Drug Policy, <QuerySet []>
  7. Dean Becker, Drug Policy, <QuerySet []>
  8. Brian C. Bennett, Drug Policy, <QuerySet []>
  9. Jerry Epstein, Drug Policy, <QuerySet []>